- Previous Close
109.05 - Open
109.55 - Bid --
- Ask 103.60 x --
- Day's Range
103.60 - 109.55 - 52 Week Range
60.21 - 142.40 - Volume
2,683 - Avg. Volume
34,989 - Market Cap (intraday)
721.601M - Beta (5Y Monthly) -0.06
- PE Ratio (TTM)
56.30 - EPS (TTM)
1.84 - Earnings Date May 27, 2025 - May 31, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. Its contract laboratory services include pharmaceutical, food and beverages, soil and water, chemical and dyes, cosmetics, and construction material analysis. The company's instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. It also offers environment management, laboratory set-up and management, waste water management, and air pollution monitoring services. In addition, the company provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, and auditing. Further, it offers assaying and hallmarking services for gold and silver. The company primarily serves the pharmaceuticals, consumer products, and engineering sectors. Choksi Laboratories Limited was founded in 1982 and is based in Indore, India.
www.choksilab.comRecent News: CHOKSILA.BO
View MorePerformance Overview: CHOKSILA.BO
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHOKSILA.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHOKSILA.BO
View MoreValuation Measures
Market Cap
759.56M
Enterprise Value
1.06B
Trailing P/E
59.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.83
Price/Book (mrq)
3.30
Enterprise Value/Revenue
2.55
Enterprise Value/EBITDA
9.34
Financial Highlights
Profitability and Income Statement
Profit Margin
3.10%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
415.03M
Net Income Avi to Common (ttm)
12.85M
Diluted EPS (ttm)
1.84
Balance Sheet and Cash Flow
Total Cash (mrq)
2.17M
Total Debt/Equity (mrq)
130.38%
Levered Free Cash Flow (ttm)
--